Please enable JavaScript to continue using this application.

Compare $ARCT vs $KYTX | Chartloom

Compare

$ARCT vs $KYTX

Arcturus Therapeutics Holdings Inc · Kyverna Therapeutics Inc

ARCT

Arcturus Therapeutics Holdings Inc

KYTX

Kyverna Therapeutics Inc

Compare $ARCT vs $KYTX

Comparing Arcturus Therapeutics Holdings Inc and Kyverna Therapeutics Inc

ARCTArcturus Therapeutics Holdings Inc

KYTXKyverna Therapeutics Inc

ARCTArcturus Therapeutics Holdings Inc

Market cap

$390M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.64x

Rev growth (TTM)

-76.0%

YTD performance

119.8%

52W performance

-35.2%

FCF yield

-18.7%

KYTXKyverna Therapeutics Inc

Market cap

$389M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-27.1%

52W performance

-11.0%

FCF yield

-41.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARCT

KYTX

Detailed metrics comparison

ARCT

Arcturus Therapeutics Holdings Inc

KYTX

Kyverna Therapeutics Inc

Market Cap

ARCT$390M

KYTX$389M

Enterprise Value

ARCT$199M

KYTX$382M

Price

ARCT$13.74

KYTX$6.39

P/E Ratio

ARCTN/A

KYTXN/A

P/S Ratio

ARCT13.30x

KYTX0.00x

EV/Sales

ARCT6.78x

KYTX0.00x

EV/EBITDA

ARCT1.82x

KYTX0.00x

P/B Ratio

ARCT2.16x

KYTX2.32x

P/FCF Ratio

ARCTN/A

KYTXN/A

EV/FCF

ARCT-2.73x

KYTX-2.38x

PEG Ratio

ARCTN/A

KYTXN/A

Forward P/E (NTM)

ARCTN/A

KYTXN/A

Forward P/S (NTM)

ARCT21.64x

KYTXN/A

Revenue (TTM)

ARCT$29M

KYTX$0

Revenue Growth (YoY)

ARCT-76.0%

KYTXN/A

Forward Rev Growth

ARCT107.7%

KYTX252.6%

Gross Margin (TTM)

ARCT0.0%

KYTX0.0%

Operating Margin (TTM)

ARCT0.0%

KYTX0.0%

EBITDA Margin (TTM)

ARCT-339.0%

KYTX0.0%

Net Margin (TTM)

ARCT-317.6%

KYTX0.0%

FCF Margin (TTM)

ARCT-248.6%

KYTXN/A

Net Income (TTM)

ARCT$-93M

KYTX$-153M

FCF (TTM)

ARCT$-73M

KYTX$-160M

EPS (TTM)

ARCT-$3.28

KYTX-$2.51

ROE (TTM)

ARCT-4654.0%

KYTX-8191.0%

ROA (TTM)

ARCT-3646.0%

KYTX-6374.0%

ROIC (TTM)

ARCT-4654.0%

KYTX-7440.0%

Cash

ARCT$191M

KYTX$32M

Debt

ARCT$0

KYTX$25M

Net Cash/Debt

ARCT$191M

KYTX$7M

Current Ratio (TTM)

ARCT5.88x

KYTX9.06x

Quick Ratio (TTM)

ARCT5.76x

KYTX8.75x

Debt/Equity (TTM)

ARCT0.00x

KYTX0.15x

Debt/Assets (TTM)

ARCT0.0%

KYTX0.0%

Interest Coverage (TTM)

ARCTN/A

KYTXN/A

Net Debt/EBITDA (TTM)

ARCT0.00x

KYTX0.00x

Beta

ARCT2.60

KYTX2.11

52W Performance

ARCT-35.2%

KYTX-11.0%

YTD Performance

ARCT119.8%

KYTX-27.1%

% from 52W High

ARCT-43.2%

KYTX-53.3%

% from 52W Low

ARCT149.8%

KYTX7.2%

Asset Turnover (TTM)

ARCT0.11x

KYTX0.00x

FCF Yield (TTM)

ARCT-18.7%

KYTX-41.2%

Earnings Yield (TTM)

ARCT-23.9%

KYTX-39.3%

Dividend Yield (TTM)

ARCTN/A

KYTXN/A

Rule of 40

ARCT-324.5

KYTX0.0

EV/GP/RG

ARCTN/A

KYTXN/A

Ticker research

View ARCT research View KYTX research

Metric	ARCT Arcturus Therapeutics Holdings Inc	KYTX Kyverna Therapeutics Inc
Market & Valuation
Market Cap	$390M	$389M
Enterprise Value	$199M	$382M
Price	$13.74	$6.39
P/E Ratio	N/A	N/A
P/S Ratio	13.30x	0.00x
EV/Sales	6.78x	0.00x
EV/EBITDA	1.82x	0.00x
P/B Ratio	2.16x	2.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.73x	-2.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.64x	N/A
Revenue & Growth
Revenue (TTM)	$29M	$0
Revenue Growth (YoY)	-76.0%	N/A
Forward Rev Growth	107.7%	252.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-339.0%	0.0%
Net Margin (TTM)	-317.6%	0.0%
FCF Margin (TTM)	-248.6%	N/A
Net Income (TTM)	$-93M	$-153M
FCF (TTM)	$-73M	$-160M
EPS (TTM)	-$3.28	-$2.51
ROE (TTM)	-4654.0%	-8191.0%
ROA (TTM)	-3646.0%	-6374.0%
ROIC (TTM)	-4654.0%	-7440.0%
Financial Health
Cash	$191M	$32M
Debt	$0	$25M
Net Cash/Debt	$191M	$7M
Current Ratio (TTM)	5.88x	9.06x
Quick Ratio (TTM)	5.76x	8.75x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.11
52W Performance	-35.2%	-11.0%
YTD Performance	119.8%	-27.1%
% from 52W High	-43.2%	-53.3%
% from 52W Low	149.8%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-18.7%	-41.2%
Earnings Yield (TTM)	-23.9%	-39.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-324.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARCT research	View KYTX research

Valuation

P/S Ratio

KYTX

0.00x

ARCT

13.30x

EV/FCF

ARCT

-2.73x

KYTX

-2.38x

Growth & revenue

Revenue Growth TTM

ARCT

-76.0%

Forward Revenue Growth

KYTX

252.6%

ARCT

107.7%

Profitability & performance

Gross Margin

ARCT

0.0%

KYTX

0.0%

ROE

ARCT

-4654.0%

KYTX

-8191.0%

FCF Yield %

ARCT

-18.7%

KYTX

-41.2%

52-Week Performance

KYTX

-11.0%

ARCT

-35.2%

Detailed metrics comparison

ARCT

Arcturus Therapeutics Holdings Inc

KYTX

Kyverna Therapeutics Inc

Market Cap

ARCT$390M

KYTX$389M

Enterprise Value

ARCT$199M

KYTX$382M

Price

ARCT$13.74

KYTX$6.39

P/E Ratio

ARCTN/A

KYTXN/A

P/S Ratio

ARCT13.30x

KYTX0.00x

EV/Sales

ARCT6.78x

KYTX0.00x

EV/EBITDA

ARCT1.82x

KYTX0.00x

P/B Ratio

ARCT2.16x

KYTX2.32x

P/FCF Ratio

ARCTN/A

KYTXN/A

EV/FCF

ARCT-2.73x

KYTX-2.38x

PEG Ratio

ARCTN/A

KYTXN/A

Forward P/E (NTM)

ARCTN/A

KYTXN/A

Forward P/S (NTM)

ARCT21.64x

KYTXN/A

Revenue (TTM)

ARCT$29M

KYTX$0

Revenue Growth (YoY)

ARCT-76.0%

KYTXN/A

Forward Rev Growth

ARCT107.7%

KYTX252.6%

Gross Margin (TTM)

ARCT0.0%

KYTX0.0%

Operating Margin (TTM)

ARCT0.0%

KYTX0.0%

EBITDA Margin (TTM)

ARCT-339.0%

KYTX0.0%

Net Margin (TTM)

ARCT-317.6%

KYTX0.0%

FCF Margin (TTM)

ARCT-248.6%

KYTXN/A

Net Income (TTM)

ARCT$-93M

KYTX$-153M

FCF (TTM)

ARCT$-73M

KYTX$-160M

EPS (TTM)

ARCT-$3.28

KYTX-$2.51

ROE (TTM)

ARCT-4654.0%

KYTX-8191.0%

ROA (TTM)

ARCT-3646.0%

KYTX-6374.0%

ROIC (TTM)

ARCT-4654.0%

KYTX-7440.0%

Cash

ARCT$191M

KYTX$32M

Debt

ARCT$0

KYTX$25M

Net Cash/Debt

ARCT$191M

KYTX$7M

Current Ratio (TTM)

ARCT5.88x

KYTX9.06x

Quick Ratio (TTM)

ARCT5.76x

KYTX8.75x

Debt/Equity (TTM)

ARCT0.00x

KYTX0.15x

Debt/Assets (TTM)

ARCT0.0%

KYTX0.0%

Interest Coverage (TTM)

ARCTN/A

KYTXN/A

Net Debt/EBITDA (TTM)

ARCT0.00x

KYTX0.00x

Beta

ARCT2.60

KYTX2.11

52W Performance

ARCT-35.2%

KYTX-11.0%

YTD Performance

ARCT119.8%

KYTX-27.1%

% from 52W High

ARCT-43.2%

KYTX-53.3%

% from 52W Low

ARCT149.8%

KYTX7.2%

Asset Turnover (TTM)

ARCT0.11x

KYTX0.00x

FCF Yield (TTM)

ARCT-18.7%

KYTX-41.2%

Earnings Yield (TTM)

ARCT-23.9%

KYTX-39.3%

Dividend Yield (TTM)

ARCTN/A

KYTXN/A

Rule of 40

ARCT-324.5

KYTX0.0

EV/GP/RG

ARCTN/A

KYTXN/A

Ticker research

View ARCT research View KYTX research

Metric	ARCT Arcturus Therapeutics Holdings Inc	KYTX Kyverna Therapeutics Inc
Market & Valuation
Market Cap	$390M	$389M
Enterprise Value	$199M	$382M
Price	$13.74	$6.39
P/E Ratio	N/A	N/A
P/S Ratio	13.30x	0.00x
EV/Sales	6.78x	0.00x
EV/EBITDA	1.82x	0.00x
P/B Ratio	2.16x	2.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.73x	-2.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.64x	N/A
Revenue & Growth
Revenue (TTM)	$29M	$0
Revenue Growth (YoY)	-76.0%	N/A
Forward Rev Growth	107.7%	252.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-339.0%	0.0%
Net Margin (TTM)	-317.6%	0.0%
FCF Margin (TTM)	-248.6%	N/A
Net Income (TTM)	$-93M	$-153M
FCF (TTM)	$-73M	$-160M
EPS (TTM)	-$3.28	-$2.51
ROE (TTM)	-4654.0%	-8191.0%
ROA (TTM)	-3646.0%	-6374.0%
ROIC (TTM)	-4654.0%	-7440.0%
Financial Health
Cash	$191M	$32M
Debt	$0	$25M
Net Cash/Debt	$191M	$7M
Current Ratio (TTM)	5.88x	9.06x
Quick Ratio (TTM)	5.76x	8.75x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.11
52W Performance	-35.2%	-11.0%
YTD Performance	119.8%	-27.1%
% from 52W High	-43.2%	-53.3%
% from 52W Low	149.8%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-18.7%	-41.2%
Earnings Yield (TTM)	-23.9%	-39.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-324.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARCT research	View KYTX research